Wells Fargo & Company Cuts Docusign (NASDAQ:DOCU) Price Target to $60.00

Docusign (NASDAQ:DOCU) had its target price lowered by Wells Fargo & Company from $75.00 to $60.00 in a report released on Wednesday,Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the stock.

Other research analysts have also issued research reports about the stock. Piper Sandler lowered their price objective on shares of Docusign from $90.00 to $75.00 and set a “neutral” rating for the company in a research note on Friday, December 5th. Zacks Research lowered shares of Docusign from a “strong-buy” rating to a “hold” rating in a report on Monday, November 24th. UBS Group decreased their price target on shares of Docusign from $85.00 to $75.00 and set a “neutral” rating for the company in a research report on Friday, December 5th. BTIG Research restated a “buy” rating and issued a $70.00 price target on shares of Docusign in a research note on Wednesday. Finally, Wedbush reduced their price objective on Docusign from $85.00 to $75.00 and set a “neutral” rating on the stock in a research note on Friday, December 5th. Five investment analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company’s stock. According to MarketBeat.com, Docusign has a consensus rating of “Hold” and a consensus target price of $66.67.

Docusign Trading Down 1.1%

DOCU stock opened at $47.23 on Wednesday. The business’s fifty day moving average price is $49.82 and its 200 day moving average price is $64.03. Docusign has a 12-month low of $40.16 and a 12-month high of $94.67. The company has a market capitalization of $9.46 billion, a PE ratio of 31.91, a P/E/G ratio of 2.08 and a beta of 1.03.

Docusign (NASDAQ:DOCU) last released its earnings results on Tuesday, March 17th. The company reported $1.01 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.06. The company had revenue of $836.86 million during the quarter, compared to the consensus estimate of $828.23 million. Docusign had a return on equity of 16.86% and a net margin of 9.60%.Docusign’s revenue was up 7.8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.86 EPS. Research analysts predict that Docusign will post 1.17 EPS for the current fiscal year.

Docusign declared that its Board of Directors has authorized a stock buyback plan on Tuesday, March 17th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the company to repurchase up to 21% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s board believes its stock is undervalued.

Insider Buying and Selling at Docusign

In other news, insider Robert Chatwani sold 16,696 shares of Docusign stock in a transaction on Wednesday, March 18th. The stock was sold at an average price of $48.10, for a total value of $803,077.60. Following the completion of the sale, the insider owned 72,458 shares of the company’s stock, valued at $3,485,229.80. The trade was a 18.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider James P. Shaughnessy sold 12,000 shares of Docusign stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $67.03, for a total value of $804,360.00. Following the completion of the sale, the insider owned 54,550 shares of the company’s stock, valued at $3,656,486.50. This trade represents a 18.03% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 68,173 shares of company stock valued at $4,324,684. 1.01% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Docusign

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Norges Bank purchased a new position in Docusign during the fourth quarter worth approximately $186,795,000. Capital World Investors grew its stake in shares of Docusign by 38.1% during the 4th quarter. Capital World Investors now owns 5,815,804 shares of the company’s stock valued at $397,801,000 after buying an additional 1,603,900 shares during the period. Woodline Partners LP grew its stake in shares of Docusign by 24,412.7% during the 3rd quarter. Woodline Partners LP now owns 958,938 shares of the company’s stock valued at $69,130,000 after buying an additional 955,026 shares during the period. Arrowstreet Capital Limited Partnership increased its holdings in shares of Docusign by 46.1% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 3,001,132 shares of the company’s stock worth $205,277,000 after buying an additional 946,512 shares during the last quarter. Finally, Marshall Wace LLP raised its position in shares of Docusign by 1,575.5% in the 4th quarter. Marshall Wace LLP now owns 888,411 shares of the company’s stock worth $60,767,000 after buying an additional 835,388 shares during the period. Institutional investors and hedge funds own 77.64% of the company’s stock.

More Docusign News

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Q4 beat — DocuSign reported Q4 revenue and EPS modestly above consensus and reiterated growth guidance, showing continued subscription momentum and giving a near‑term fundamental support for the stock. Proactive: DocuSign beats Q4 estimates
• Positive Sentiment: Large buyback authorized — The board approved a $2.0 billion increase (bringing total authorization to roughly $2.6B), representing a material portion of market cap; buybacks are a direct capital‑allocation tool that can support the share price and signal management confidence. DocuSign press release: buyback
• Neutral Sentiment: Higher trading volume — Volume spiked after the earnings release, which raises short‑term volatility and can amplify both rebounds and selloffs depending on flow. American Banking News: Volume Increase After Earnings
• Neutral Sentiment: Short‑interest reporting appears inconsistent — March short‑interest entries in the feed show anomalous “0”/NaN values, so there’s no clear short‑flow signal from these data points at this time.
• Negative Sentiment: Analyst cuts and cautious notes — Multiple major brokerages trimmed price targets and moved to more cautious ratings (examples include Morgan Stanley, RBC, UBS, JPMorgan, Piper Sandler, Wells Fargo and others), reducing near‑term upside expectations and contributing to selling pressure. American Banking News: Morgan Stanley Lowers Price Target
• Negative Sentiment: Insider sale disclosed — Senior executive Robert Chatwani sold ~16.7k shares (~$803k); while single insider sales can be routine, the filing has weighed on sentiment alongside the analyst downgrades. SEC Form 4: Insider Sale

About Docusign

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.